Malcovati L - Search Results

1

Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.

Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L, Cazzola M, Park S, Itzykson R, Ades L, Fenaux P, Jadersten M, Hellstrom-Lindberg E, Gale RP, Beach CL, Lee SJ, Horowitz MM, Greenberg PL, Tallman MS, DiPersio JF, Bunjes D, Weisdorf DJ, Cutler C. Koreth J, et al. Among authors: malcovati l. J Clin Oncol. 2013 Jul 20;31(21):2662-70. doi: 10.1200/JCO.2012.46.8652. Epub 2013 Jun 24. J Clin Oncol. 2013. PMID: 23797000 Free PMC article.

2

Myelodysplastic syndromes--coping with ineffective hematopoiesis.

Cazzola M, Malcovati L. Cazzola M, et al. Among authors: malcovati l. N Engl J Med. 2005 Feb 10;352(6):536-8. doi: 10.1056/NEJMp048266. N Engl J Med. 2005. PMID: 15703418 No abstract available.

3

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M. Malcovati L, et al. J Clin Oncol. 2005 Oct 20;23(30):7594-603. doi: 10.1200/JCO.2005.01.7038. Epub 2005 Sep 26. J Clin Oncol. 2005. PMID: 16186598

4

Predicting survival and leukemic evolution in patients with myelodysplastic syndrome.

Malcovati L, Della Porta MG, Cazzola M. Malcovati L, et al. Haematologica. 2006 Dec;91(12):1588-90. Haematologica. 2006. PMID: 17145593 No abstract available.

5

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.

Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M. Malcovati L, et al. J Clin Oncol. 2007 Aug 10;25(23):3503-10. doi: 10.1200/JCO.2006.08.5696. J Clin Oncol. 2007. PMID: 17687155

6

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.

Boultwood J, Pellagatti A, Cattan H, Lawrie CH, Giagounidis A, Malcovati L, Della Porta MG, Jädersten M, Killick S, Fidler C, Cazzola M, Hellström-Lindberg E, Wainscoat JS. Boultwood J, et al. Among authors: malcovati l. Br J Haematol. 2007 Nov;139(4):578-89. doi: 10.1111/j.1365-2141.2007.06833.x. Epub 2007 Oct 3. Br J Haematol. 2007. PMID: 17916100 Free article.

7

Supportive care, growth factors, and new therapies in myelodysplastic syndromes.

Hellström-Lindberg E, Malcovati L. Hellström-Lindberg E, et al. Among authors: malcovati l. Blood Rev. 2008 Mar;22(2):75-91. doi: 10.1016/j.blre.2007.10.003. Epub 2008 Feb 20. Blood Rev. 2008. PMID: 18068281 Review.

8

Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.

Travaglino E, Benatti C, Malcovati L, Della Porta MG, Gallì A, Bonetti E, Rosti V, Cazzola M, Invernizzi R. Travaglino E, et al. Among authors: malcovati l. Eur J Haematol. 2008 Mar;80(3):216-26. doi: 10.1111/j.1600-0609.2007.01012.x. Epub 2007 Dec 10. Eur J Haematol. 2008. PMID: 18081721

9

Myelodysplastic/myeloproliferative disorders.

Malcovati L, Cazzola M. Malcovati L, et al. Haematologica. 2008 Jan;93(1):4-6. doi: 10.3324/haematol.11374. Haematologica. 2008. PMID: 18166777 Free article. No abstract available.

10

Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.

Hellström-Lindberg E, Malcovati L. Hellström-Lindberg E, et al. Among authors: malcovati l. Semin Hematol. 2008 Jan;45(1):14-22. doi: 10.1053/j.seminhematol.2007.10.004. Semin Hematol. 2008. PMID: 18179965 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page